Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-01-16 Sale |
2024-01-18 6:18 pm |
AN2 Therapeutics Inc. | ANTX | Adjuvant Global Health Technology Fund L.P. Adjuvant Global Health Technology Fund DE L.P. Adjuvant Capital GP L.P. Adjuvant Capital Management LLC 10% Owner |
100,000 | $19.65 | $1,965,000 | 2,373,500 (Indirect Direct) |
View |
| 2023-11-14 Sale |
2023-11-16 6:59 pm |
AN2 Therapeutics Inc. | ANTX | Adjuvant Global Health Technology Fund L.P. Adjuvant Global Health Technology Fund DE L.P. Adjuvant Capital GP L.P. Adjuvant Capital Management LLC 10% Owner |
1,810 | $16.15 | $29,224 | 2,473,500 (Indirect Direct) |
View |
| 2023-09-29 Sale |
2023-10-03 7:13 pm |
AN2 Therapeutics Inc. | ANTX | Adjuvant Global Health Technology Fund L.P. Adjuvant Global Health Technology Fund DE L.P. Adjuvant Capital GP L.P. Adjuvant Capital Management LLC 10% Owner |
104,773 | $16.27 | $1,704,513 | 2,475,310 (Indirect Direct) |
View |
| 2023-09-27 Sale |
2023-09-29 5:41 pm |
AN2 Therapeutics Inc. | ANTX | Adjuvant Global Health Technology Fund L.P. Adjuvant Global Health Technology Fund DE L.P. Adjuvant Capital GP L.P. Adjuvant Capital Management LLC 10% Owner |
9,357 | $16.11 | $150,708 | 2,580,083 (Indirect Direct) |
View |
| 2023-09-13 Sale |
2023-09-15 5:17 pm |
AN2 Therapeutics Inc. | ANTX | Adjuvant Global Health Technology Fund L.P. Adjuvant Global Health Technology Fund DE L.P. Adjuvant Capital GP L.P. Adjuvant Capital Management LLC 10% Owner |
400 | $16 | $6,400 | 2,589,440 (Indirect Direct) |
View |
| 2023-09-06 Sale |
2023-09-08 4:59 pm |
AN2 Therapeutics Inc. | ANTX | Adjuvant Global Health Technology Fund L.P. Adjuvant Global Health Technology Fund DE L.P. Adjuvant Capital GP L.P. Adjuvant Capital Management LLC 10% Owner |
7,140 | $16.03 | $114,484 | 2,589,840 (Indirect Direct) |
View |
| 2023-08-23 Sale |
2023-08-25 4:31 pm |
AN2 Therapeutics Inc. | ANTX | Adjuvant Global Health Technology Fund L.P. Adjuvant Global Health Technology Fund DE L.P. Adjuvant Capital GP L.P. Adjuvant Capital Management LLC 10% Owner |
400 | $16 | $6,400 | 2,596,980 (Indirect Direct) |
View |
| 2022-03-29 Purchase(A) |
2022-06-24 4:51 pm |
AN2 Therapeutics Inc. | ANTX | Adjuvant Global Health Technology Fund L.P. Adjuvant Global Health Technology Fund DE L.P. Adjuvant Capital GP L.P. Adjuvant Capital Management LLC 10% Owner |
166,666 | $15 | $2,499,990 | 2,597,380 (Indirect Direct) |
View |
| 2022-03-29 Purchase |
2022-03-31 8:15 pm |
AN2 Therapeutics Inc. | ANTX | Adjuvant Global Health Technology Fund L.P. Adjuvant Global Health Technology Fund DE L.P. 10% Owner |
166,666 | $15 | $2,499,990 | 2,210,735 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-06-06 Other |
2022-06-24 5:06 pm |
N/A N/A |
AN2 Therapeutics Inc. | ANTX | Adjuvant Global Health Technology Fund L.P. Adjuvant Global Health Technology Fund DE L.P. Adjuvant Capital GP L.P. Adjuvant Capital Management LLC 10% Owner |
26,511 | $15 | 2,650,402 (Direct) |
View |
| 2022-03-29 Conversion(A) |
2022-06-24 4:51 pm |
N/A N/A |
AN2 Therapeutics Inc. | ANTX | Adjuvant Global Health Technology Fund L.P. Adjuvant Global Health Technology Fund DE L.P. Adjuvant Capital GP L.P. Adjuvant Capital Management LLC 10% Owner |
2,430,714 | $0 | 2,597,380 (Direct) |
View |
Ownership(A) |
2022-06-24 4:48 pm |
N/A N/A |
AN2 Therapeutics Inc. | ANTX | Adjuvant Global Health Technology Fund L.P. Adjuvant Global Health Technology Fund DE L.P. Adjuvant Capital GP L.P. Adjuvant Capital Management LLC 10% Owner |
0 | $0 | 2,430,714 (Direct) |
View |
| 2022-03-29 Conversion |
2022-03-31 8:15 pm |
N/A N/A |
AN2 Therapeutics Inc. | ANTX | Adjuvant Global Health Technology Fund L.P. Adjuvant Global Health Technology Fund DE L.P. 10% Owner |
2,430,714 | $0 | 2,210,735 (Indirect) |
View |
Ownership |
2022-03-24 9:16 pm |
N/A N/A |
AN2 Therapeutics Inc. | ANTX | Adjuvant Global Health Technology Fund L.P. Adjuvant Global Health Technology Fund DE L.P. 10% Owner |
0 | $0 | 2,430,714 (Indirect) |
View |